Study finds women lost more of their body weight on average with semaglutide than men

FHS
June 26, 2024
9:58 am

Researchers performed a secondary analysis of the semaglutide treatment effect in people with obesity and heart failure with a preserved left ventricular ejection fraction program that included individuals with diabetes mellitus, stratified by biological sex.

Democrats urge government to rein in Medicare Advantage overpayments and denials

The Biden administration is about to set the ground rules for next year’s Medicare Advantage plans, and two Democratic lawmakers want the government to aggressively

January 26, 2024

Researchers identify crucial risk factors for cognitive decline after stroke

Study identifies key risk factors for post-stroke cognitive impairment and dementia, emphasizing the importance of early detection and management of these conditions.

December 17, 2023

Public health experts outline critical steps in handling HPAI H5N1 spread

Highly pathogenic H5N1 avian influenza A virus (HPAI H5N1) remains a low risk to the general public, and public health experts in the United States

January 2, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.